NRT Smoking Cessation Aids in Lithuania
Euromonitor International's NRT Smoking Cessation Aids in Lithuania market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 37 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
NRT gum; NRT inhalators; NRT lozenges; NRT patches; Other NRT
Table of contents
NRT SMOKING CESSATION AIDS IN LITHUANIA : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 1 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 2 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 3 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 4 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 5 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 6 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 7 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - LITHUANIA
SANITAS AB - OTC HEALTHCARE - LITHUANIA
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Summary - Sanitas AB: Key Facts
Summary 2 Summary - Sanitas AB (Without Group Companies): Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
Summary 3 Summary - Sanitas AB: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 4 Summary - Sanitas AB: Competitive Position 2008
SICOR BIOTECH UAB - OTC HEALTHCARE - LITHUANIA
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Summary - SICOR Biotech UAB: Key Facts
Summary 6 Summary - SICOR Biotech UAB: Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
VALENTIS UAB - OTC HEALTHCARE - LITHUANIA
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Summary - Valentis UAB: Key Facts
Summary 8 Summary - Valentis UAB: Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Summary - Valentis UAB: Competitive Position 2008
OTC HEALTHCARE IN LITHUANIA
EXECUTIVE SUMMARY
Deteriorating Economic Climate Slows Down OTC Healthcare's Development
Average Unit Price Is Rising
Advertising Helps Multinationals to Dominate the Market
Chemists/Pharmacies Reaches Saturation
Further Market Development Hampered by Economic Problems
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 9 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 10 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 11 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 12 OTC Healthcare Company Shares by Value 2004-2008
Table 13 OTC Healthcare Brand Shares by Value 2005-2008
Table 14 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 15 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 16 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 17 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
Summary 10 Summary - OTC Healthcare Switches 2005-2008
DEFINITIONS
Summary 11 Summary - Research Sources
SANITAS AB
Strategic Direction
Key Facts
Summary 12 Summary - Sanitas AB: Key Facts
Summary 13 Summary - Sanitas AB (Without Group Companies): Operational Indicators 2005-2007
Company Background
Production
Summary 14 Summary - Sanitas AB: Production Statistics 2007
Competitive Positioning
Summary 15 Summary - Sanitas AB: Competitive Position 2008
SICOR BIOTECH UAB
Strategic Direction
Key Facts
Summary 16 Summary - SICOR Biotech UAB: Key Facts
Summary 17 Summary - SICOR Biotech UAB: Operational Indicators 2005-2007
Company Background
Production
Competitive Positioning
VALENTIS UAB
Strategic Direction
Key Facts
Summary 18 Summary - Valentis UAB: Key Facts
Summary 19 Summary - Valentis UAB: Operational Indicators 2005-2007
Company Background
Production
Competitive Positioning
Summary 20 Summary - Valentis UAB: Competitive Position 2008